Full video transcriptClick to expand
Auto-generated transcript of @rokkzillaa's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Something that's not talked about enough is how many women use peptides.
- 0:04Like a lot of women use peptides for the day to be alive.
- 0:07And I was actually able to get a list of like the top five peptides I wanted to use.
- 0:11Number five is going to be PT-141.
- 0:14This is like for people who deal with sexual dysfunction.
- 0:16It's not just women, but also men.
- 0:18And it helps with low libido or menopause, things of that sort.
- 0:23Number four is going to be melanogen.
- 0:25So this is like the permanent tan peptide.
- 0:28Like you ever see these Instagram models, you people who are like literally tan 24-7.
- 0:33Like this is what they're using.
- 0:34That's something you should use.
- 0:35Probably if you hate being fucking tailed.
- 0:38Number three is going to be BPC-157.
- 0:40I myself use BPC-157, but a lot of women use it.
- 0:43Especially women who are into fitness because they have a lot of pain with their joints
- 0:47or tendons.
- 0:48But something a lot of people don't know is that it helps with your gut health.
- 0:50Number two is going to be CJC with Ippamrela.
- 0:53Now I myself am actually on CJC, but I'm on CJC with that.
- 0:57So that's a drug-definity complex, but DM me if you have questions about that.
- 1:02But most women use this for anti-aging sleep.
- 1:04This is going to be like a girl pormol releasing peptides.
- 1:08So it's good for skin, sleep, protein sepheses.
- 1:11And then the last one, I read two studies here.
- 1:13It says the similar blue tie, trisepitide.
- 1:15But I disagree, I believe that it's red or street tie.
- 1:18This is one of the, I wouldn't even say up and coming peptides.
- 1:22It's definitely a staple indefinitely.
- 1:24A peptide that's flying off the shelves.
- 1:26That's helping people burn fat, but also allowing them to hold on and retain as much
- 1:30muscle as possible.
- 1:31If you have one of these peptides in front of you, which one would you grab?
Peptide rankings on TikTok: gym culture hype vs. actual evidence
Quick answer
The creator discusses five peptides marketed toward women for libido, tanning, joint recovery, growth hormone stimulation, and weight management. Of the five, only PT-141 (bremelanotide) and tirzepatide carry FDA approval, and both have specific approved indications that the creator either mischaracterized or expanded beyond the evidence. Melanotan II, BPC-157, and compounded CJC-1295/ipamorelin blends exist outside approved regulatory frameworks, and their safety and efficacy profiles in humans remain under-studied relative to the claims made in the video.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide rankings on TikTok: gym culture hype vs. actual evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Peptide rankings on TikTok: gym culture hype vs. actual evidence should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide rankings on TikTok: gym culture hype vs. actual evidence" from rokkzillaa. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator discusses five peptides marketed toward women for libido, tanning, joint recovery, growth hormone stimulation, and weight management.
The reason this review is not generic is the source wording and the canonical claim label "peptides number 1 is debatable my clients order it more than anything." In this clip, the useful excerpt is: "Something that's not talked about enough is how many women use peptides." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator discusses five peptides marketed toward women for libido, tanning, joint recovery, growth hormone stimulation, and weight management.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator discusses five peptides marketed toward women for libido, tanning, joint recovery, growth hormone stimulation, and weight management. Of the five, only PT-141 (bremelanotide) and tirzepatide carry FDA approval, and both have specific approved indications that the creator either mischaracterized or expanded beyond the evidence. Melanotan II, BPC-157, and compounded CJC-1295/ipamorelin blends exist outside approved regulatory frameworks, and their safety and efficacy profiles in humans remain under-studied relative to the claims made in the video.
- PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder in premenopausal women only, per the 2019 Phase 3 trial data published in Obstetrics and Gynecology.
- Melanotan II has no FDA or EMA approval, produces temporary not permanent pigmentation, and has been linked to melanocytic skin changes in published case literature.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder in premenopausal women only, per the 2019 Phase 3 trial data published in Obstetrics and Gynecology.
- Melanotan II has no FDA or EMA approval, produces temporary not permanent pigmentation, and has been linked to melanocytic skin changes in published case literature.
- BPC-157's gut and tendon effects come almost entirely from rodent studies. As of 2024, there are no large-scale human randomized controlled trials confirming the claims made in this video.
- The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) confirmed tirzepatide's fat loss effects, but the same data showed lean mass loss alongside fat loss, contradicting the muscle-retention claim.
- Compounded peptides like BPC-157 and CJC-1295/ipamorelin blends are not equivalent to FDA-approved drugs. The FDA has specifically warned consumers about compounded peptides marketed without approval.
- Directing followers to "DM me" for medical guidance on hormone-affecting compounds is not a substitute for evaluation by a licensed provider with access to labs and a full medical history.
- Of the five peptides listed, only two, PT-141 and tirzepatide, have FDA-approved indications. Both require a valid prescription from a licensed clinician.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @rokkzillaa actually say?
The creator ran through a ranked list of five peptides they claim women use most, covering sexual dysfunction, tanning, joint repair, growth hormone release, and fat loss. The framing was casual and confident, but several of the claims deserve a closer look before anyone pulls out a credit card.
Specifically, they said PT-141 helps with "low libido or menopause," that melanotan gives a "permanent tan," that BPC-157 helps "gut health," that CJC-1295 with ipamorelin is good for "anti-aging sleep" and "protein synthesis," and that tirzepatide, which they called "rezerpatide" and then corrected, helps "burn fat" while people "hold on and retain as much muscle as possible." That last claim is the most loaded and the most worth unpacking.
Does the science back this up?
Some of it does, some of it doesn't, and some of it is so far ahead of the clinical evidence that calling it established is a stretch. Let's go compound by compound.
PT-141 (bremelanotide): This one is actually FDA-approved for hypoactive sexual desire disorder in premenopausal women, under the brand name Vyleesi. So the libido claim has real regulatory backing. However, the creator extends this to menopause without qualification. The approved indication is specifically premenopausal. Palatin Technologies funded the Phase 3 trials published in Obstetrics and Gynecology (2019), and the data do not extend cleanly to menopausal populations.
Melanotan: The creator calls it "the permanent tan peptide." Nothing about melanotan is permanent. More importantly, melanotan II has no FDA approval, has been linked to melanocytic lesion changes, and the European Medicines Agency has warned against its use. Calling it something people "should use" if they hate being pale is irresponsible framing.
BPC-157: The gut health claim has some animal-model support. Sikiric et al. have published extensively on BPC-157's gastroprotective effects in rodents going back to the 1990s and into the 2010s. Human trials are scarce. Joint and tendon claims also rely almost entirely on animal data. This is a compound that shows real promise in preclinical work, but "I myself use BPC-157" is not a clinical endorsement.
CJC-1295 with ipamorelin: These are growth hormone secretagogues. There is legitimate research on GHRH analogs for sleep quality and body composition, but the combination as a compounded product has not been through robust human clinical trials. The FDA has raised concerns about compounded peptides specifically. Calling this good for "protein synthesis" without a citation is vague at best.
Tirzepatide: The creator struggled with the name but landed on the right compound. Tirzepatide (Mounjaro, Zepbound) is FDA-approved for type 2 diabetes and obesity. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed meaningful fat loss. Muscle retention on GLP-1/GIP agonists is an active research question, not a settled fact.
What did they get wrong (or right)?
They got PT-141's mechanism right but oversimplified the indication. Credit where it's due: bremelanotide does work on melanocortin receptors to influence desire, and it is clinically recognized for that purpose in the right population.
They got melanotan badly wrong. Describing it as something you "should use" without mentioning it has no regulatory approval and has documented safety signals is a real problem. The European Medicines Agency flagged it in 2014. Skin changes from melanotan II, including new and changing moles, have been reported in the literature (Dawson et al., 2010, Journal of the European Academy of Dermatology and Venereology). This claim needed a warning, not a sales pitch.
The tirzepatide muscle-retention claim is unverified. Some data from SURMOUNT trials show lean mass loss alongside fat loss, which is the opposite of what was implied. Researchers are actively studying resistance training as a countermeasure. The creator presented this as settled when it is not.
What should you actually know?
Most of these compounds exist in a regulatory gray zone. PT-141 and tirzepatide are FDA-approved drugs, but the others on this list are not approved for the uses described. Melanotan II cannot legally be sold as a drug or supplement in the US or EU. Compounded BPC-157 and CJC-1295/ipamorelin combinations are not the same as approved pharmaceuticals, and the FDA has taken action against compounders marketing unapproved peptides.
The creator mentions "DM me if you have questions" about CJC combinations. That is not a substitute for a licensed prescriber who knows your full health history, current medications, and relevant labs. Any peptide that affects hormone pathways, appetite, skin pigmentation, or tissue repair can have interactions and contraindications that a TikTok comment thread cannot catch.
- Tirzepatide is a prescription drug. It cannot be legally dispensed without a valid prescription from a licensed provider.
- Melanotan II is not FDA-approved and carries documented skin safety concerns.
- BPC-157 and ipamorelin have no FDA-approved human indications as of 2024.
- Anyone considering these compounds should consult a licensed telehealth provider who can review labs and medical history before prescribing.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
rokkzillaa · TikTok creator
11.5K views on this video
Number 1 is debatable… my clients order it more than anything else. #gymrat #gymtok
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about pt-141 (bremelanotide)?
PT-141 (bremelanotide) is FDA-approved for hypoactive sexual desire disorder in premenopausal women only, per the 2019 Phase 3 trial data published in Obstetrics and Gynecology.
What does the video say about melanotan ii has no fda?
Melanotan II has no FDA or EMA approval, produces temporary not permanent pigmentation, and has been linked to melanocytic skin changes in published case literature.
What does the video say about bpc-157's gut?
BPC-157's gut and tendon effects come almost entirely from rodent studies. As of 2024, there are no large-scale human randomized controlled trials confirming the claims made in this video.
What does the video say about the surmount-1 trial (jastreboff et al., 2022, nejm) confirmed tirzepatide's?
The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) confirmed tirzepatide's fat loss effects, but the same data showed lean mass loss alongside fat loss, contradicting the muscle-retention claim.
What does the video say about compounded peptides like bpc-157?
Compounded peptides like BPC-157 and CJC-1295/ipamorelin blends are not equivalent to FDA-approved drugs. The FDA has specifically warned consumers about compounded peptides marketed without approval.
What does the video say about directing followers to "dm me" for medical guidance on hormone-affecting?
Directing followers to "DM me" for medical guidance on hormone-affecting compounds is not a substitute for evaluation by a licensed provider with access to labs and a full medical history.
Sources & references
- [1]Jastreboff et al., 2022
- [2]Dawson et al., 2010
- [3]Obstetrics and Gynecology (2019)
- [4]Gynecology (2019)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by rokkzillaa, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.